Here, we highlight the success of identification of tumor-targeting peptides against purified and isolated proteins involved in tumor malignancy such as cancer stem cell markers, matrix metalloproteinases (MMP2, MMP9), growth receptor bound protein 7 (Grb7), and epidermal growth factor receptor (EGFR). The gene discussed is MMP9; the disease is neoplasm.